EUVIMEDOpdag EUVIMED
Crossref

Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering

Yi Wolf Zhang iD, Nai-Pin Lin, Xu Guo, Nicolas Szabo-Fresnais, Peter J Ortoleva iD, Danny Hung-Chieh Chou iD

ACS Chemical Biology · 2024-02-16 · 19 (2) · 506-515

DOI: 10.1021/acschembio.3c00685 ↗

At a glance

Journal article in ACS Chemical Biology, published online on 2024-01-24. Written by Yi Wolf Zhang and 5 co-authors. Institution: Department of Pediatrics, Division of Diabetes and Endocrinology, Stanford University, Palo Alto, California 94304, United States. Major MEDLINE topics: Peptide Library, Bacteriophages. Cited 5 times so far (Crossref); 56 references. Funded by: NIDDK NIH HHS, NIGMS NIH HHS, Lilly Endowment.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chemical and enzymatic modifications of peptide-displayed libraries have been successfully employed to expand the phage display library. However, the requirement of specific epitopes and scaffolds has limited the scope of protein engineering using phage display. In this study, we present a novel approach utilizing omniligase-1-mediated selective and specific ligation on the phage pIII protein, offering a high conversion rate and compatibility with commercially available phage libraries. We applied this method to perform high-throughput engineering of insulin analogues with randomized B chain C-terminal regions. Insulin analogues with different B chain C-terminal segments were selected and exhibited biological activity equivalent to that of human insulin. Molecular dynamics studies of insulin analogues revealed a novel interaction between the insulin B27 residue and insulin receptor L1 domain. In summary, our findings highlight the potential of omniligase-1-mediated phage display in the development and screening of disulfide-rich peptides and proteins. This approach holds promise for the creation of novel insulin analogues with enhanced therapeutic properties and exhibits potential for the development of other therapeutic compounds.

Subjects

MeSH terms (MEDLINE)

Peptide LibraryBacteriophagesHumansInsulinPeptidesProteins

Substances

Peptide LibraryInsulinPeptidesProteins

Authors and institutions

  • Department of Pediatrics, Division of Diabetes and Endocrinology, Stanford University, Palo Alto, California 94304, United States.
  • Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112, United States.
  • Department of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.

ORCID profiles: Yi Wolf Zhang, Peter J Ortoleva, Danny Hung-Chieh Chou

Funding

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • Lilly Endowment
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of General Medical Sciences

Cite

APA

Zhang, Y. W., Lin, N. P., Guo, X., Szabo-Fresnais, N., Ortoleva, P. J., & Chou, D. H. (2024). Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering. ACS Chemical Biology, 19(2), 506-515. https://doi.org/10.1021/acschembio.3c00685

Vancouver

Zhang YW, Lin NP, Guo X, Szabo-Fresnais N, Ortoleva PJ, Chou DH. Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering. ACS Chemical Biology. 2024;19(2):506-515. doi:10.1021/acschembio.3c00685

BibTeX
@article{Zhang2024,
  author = {Zhang, Yi Wolf and Lin, Nai-Pin and Guo, Xu and Szabo-Fresnais, Nicolas and Ortoleva, Peter J and Chou, Danny Hung-Chieh},
  title = {Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering},
  journal = {ACS Chemical Biology},
  year = {2024},
  volume = {19},
  number = {2},
  pages = {506--515},
  doi = {10.1021/acschembio.3c00685}
}
Start for free →